A role for TRPV1 in influencing the onset of cardiovascular disease in obesity

Hypertension

Volumn 61, Issue 1, 2013, Pages 246-252

  Marshall, Nichola J ^a   Liang, Lihuan ^a   Bodkin, Jennifer ^a   Dessapt Baradez, Cecile ^a   Nandi, Manasi ^a   Collot Teixeira, Sophie ^a   Smillie, Sarah Jane ^a   Lalgi, Kamal ^a   Fernandes, Elizabeth S ^a   Gnudi, Luigi ^a   Brain, Susan D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

glucose intolerance; hypertension; mice; obesity; TRPV1 protein, mouse

Indexed keywords

ADIPONECTIN; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL HYPERTROPHY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART RATE; HEART WEIGHT; KIDNEY MASS; KNOCKOUT MOUSE; LIPID DIET; MALE; METABOLIC SYNDROME X; MOUSE; NOCICEPTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; VASCULAR DISEASE; VASCULAR RESISTANCE; WEIGHT GAIN; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIET, HIGH-FAT; HYPERTENSION; INSULIN RESISTANCE; INTERLEUKIN-10; INTERLEUKIN-1BETA; LEPTIN; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; TRPV CATION CHANNELS;

EID: 84871610618     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.201434     Document Type: Article

References (35)

1. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389:816-824. (Pubitemid 27462969)
2. Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev. 2004;84:903-934. (Pubitemid 38823770)
3. Vriens J, Appendino G, Nilius B. Pharmacology of vanilloid transient receptor potential cation channels. Mol Pharmacol. 2009;75:1262-1279.
4. Caterina MJ, Leffer A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D. Impaired nocicep-tion and pain sensation in mice lacking the capsaicin receptor. Science. 2000;288:306-313. (Pubitemid 30226186)
5. Fernandes ES, Russell FA, Spina D, McDougall JJ, Graepel R, Gentry C, Staniland AA, Mountford DM, Keeble JE, Malcangio M, Bevan S, Brain SD. A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor α-induced infammatory hyperalgesia and Freund's complete adjuvant-induced mon-arthritis. Arthritis Rheum. 2011;63:819-829.
6. Starr A, Graepel R, Keeble J, Schmidhuber S, Clark N, Grant A, Shah AM, Brain SD. A reactive oxygen species-mediated component in neuro-genic vasodilatation. Cardiovasc Res. 2008;78:139-147. (Pubitemid 351430963)
7. Keeble J, Russell F, Curtis B, Starr A, Pinter E, Brain SD. Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint infammation. Arthritis Rheum. 2005;52:3248-3256. (Pubitemid 41447108)
8. Fernandes ES, Liang L, Smillie SJ, Kaiser F, Purcell R, Rivett DW, Alam S, Howat S, Collins H, Thompson SJ, Keeble JE, Riffo-Vasquez Y, Bruce KD, Brain SD. TRPV1 deletion enhances local infammation and accelerates the onset of systemic infammatory response syndrome. J Immunol. 2012;188:5741-5751.
9. Zhong B, Wang DH. TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice. Am J Physiol Heart Circ Physiol. 2007;293:H1791-H1798. (Pubitemid 47367229)
10. Huang R, Karve A, Shah I, Bowers MC, DiPette DJ, Supowit SC, Abela GS. Deletion of the mouse alpha-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2008;294:H1291-H1297. (Pubitemid 351468726)
11. Wang Y, Wang DH. Aggravated renal infammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Am J Physiol Renal Physiol. 2009;297:F1550-F1559.
12. Zhang LL, Yan Liu D, Ma LQ, Luo ZD, Cao TB, Zhong J, Yan ZC, Wang LJ, Zhao ZG, Zhu SJ, Schrader M, Thilo F, Zhu ZM, Tepel M. Activation of transient receptor potential vanilloid type-1 channel prevents adipogen-esis and obesity. Circ Res. 2007;100:1063-1070. (Pubitemid 46598931)
13. Motter AL, Ahern GP. TRPV1-null mice are protected from diet-induced obesity. FEBS Lett. 2008;582:2257-2262.
14. Gram DX, Ahrén B, Nagy I, Olsen UB, Brand CL, Sundler F, Tabanera R, Svendsen O, Carr RD, Santha P, Wierup N, Hansen AJ. Capsaicin-sensitive sensory fbers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes. Eur J Neurosci. 2007;25:213-223. (Pubitemid 46096235)
15. Gram DX, Hansen AJ. The role of TRPV1 in impaired glucose tolerance in mice. Presented at European Neuropeptides Meeting, Santorini. 2007 (Abstract page 26).
16. Suri A, Szallasi A. The emerging role of TRPV1 in diabetes and obesity. Trends Pharmacol Sci. 2008;29:29-36.
17. Liang L, Tam CW, Pozsgai G, Siow R, Clark N, Keeble J, Husmann K, Born W, Fischer JA, Poston R, Shah A, Brain SD. Protection of angioten-sin II-induced vascular hypertrophy in vascular smooth muscle-targeted receptor activity-modifying protein 2 transgenic mice. Hypertension. 2009;54:1254-1261.
18. Tanaka H, Shimaya A, Kiso T, Kuramochi T, Shimokawa T, Shibasaki M. Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonist. Life Sci. 2011;88:559-563.
19. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes. 2005;54:2012-2018. (Pubitemid 40911263)
20. Reimer MK, Ahrén B. Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice. Diabetes. 2002;51(suppl 1):S138-S143. (Pubitemid 34761509)
21. Williams TD, Chambers JB, Roberts LM, Henderson RP, Overton JM. Diet-induced obesity and cardiovascular regulation in C57BL/6J mice. Clin Exp Pharmacol Physiol. 2003;30:769-778. (Pubitemid 37330525)
22. Kawada T, Hagihara K, Iwai K. Effects of capsaicin on lipid metabolism in rats fed a high-fat diet. J Nutr. 1986;116:1272-1278. (Pubitemid 16053866)
23. Snitker S, Fujishima Y, Shen H, Ott S, Pi-Sunyer X, Furuhata Y, Sato H, Takahashi M. Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications. Am J Clin Nutr. 2009;89:45-50.
24. Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z, Liu D, Arendshorst WJ, Huang Y, Tepel M, Zhu Z. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelax-ation and prevents hypertension. Cell Metab. 2010;12:130-141.
25. Andresen MC, Peters JH. TRPV1, hypertension, and cardiovascular regulation. Cell Metab. 2010;12:421; author reply 422.
26. Fève B, Bastard J P. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5:305-311.
27. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005;112:1756-1762. (Pubitemid 41372115)
28. Ruan H, Zarnowski MJ, Cushman SW, Lodish HF. Standard isolation of primary adipose cells from mouse epididymal fat pads induces infam-matory mediators and down-regulates adipocyte genes. J Biol Chem. 2003;278:47585-47593. (Pubitemid 37523202)
29. Didion SP, Kinzenbaw DA, Schrader LI, Chu Y, Faraci FM. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension. 2009;54:619-624.
30. Potenza MA, Marasciulo FL, Chieppa DM, Brigiani GS, Formoso G, Quon MJ, Montagnani M. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Circ Physiol. 2005;289:H813-H822. (Pubitemid 41129399)
31. Bratz IN, Dick GM, Tune JD, Edwards JM, Neeb ZP, Dincer UD, Sturek M. Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome. Am J Physiol Heart Circ Physiol. 2008;294:H2489-H2496.
32. Ohanyan VA, Guarini G, Thodeti CK, Talasila PK, Raman P, Haney RM, Meszaros JG, Damron DS, Bratz IN. Endothelin-mediated in vivo pressor responses following TRPV1 activation. Am J Physiol Heart Circ Physiol. 2011;301:H1135-H1142.
33. Chamberlain J, Francis S, Brookes Z, Shaw G, Graham D, Alp NJ, Dower S, Crossman DC. Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding. PLoS ONE. 2009;4:e5073.
34. Sultan A, Strodthoff D, Robertson AK, Paulsson-Berne G, Fauconnier J, Parini P, Rydén M, Thierry-Mieg N, Johansson ME, Chibalin AV, Zierath JR, Arner P, Hansson GK. T cell-mediated infammation in adipose tissue does not cause insulin resistance in hyperlipidemic mice. Circ Res. 2009;104:961-968.
35. Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Lund DD, Yorek MA. Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin. Obesity (Silver Spring). 2008;16:82-89. (Pubitemid 351271954)